Southern Hematology & Oncology is categorized under Hematologists in Birmingham, AL and active since 1990.
Southern Hematology & Oncology was established in 1990, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hematologists business, which does work in the B2C market, and is classified as a Hematologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact James Barton, Owner at the company’s single location by writing to 2022 Brookwood Medical Center Drive, Birmingham, Alabama AL 35209 or by phoning (205) 877-2888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Southern Hematology & Oncology |
Contact Person: | James Barton, Owner |
Address: | 2022 Brookwood Medical Center Drive, Birmingham, Alabama 35209 |
Phone Number: | (205) 877-2888 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 1990 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Hematologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Southern Hematology & Oncology was started in 1990 to provide professional Hematologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact James Barton, Owner for inquiries that concern Southern Hematology & Oncology by calling the company number (205) 877-2888, as your correspondence is most welcome. Additionally, the physical location of the single location of Southern Hematology & Oncology can be found at the coordinates 33.464282,-86.773956 as well as the street address 2022 Brookwood Medical Center Drive in Birmingham, Alabama 35209.
For its online presence, you may visit Southern Hematology & Oncology’s website at and engage with its social media outlets through on Twitter and on Facebook.